Jamie A. Donadio, Senior VP, CFO at Mirati Therapeutics, Inc. (MRTX), sold 7,500 shares at $75.00 ($563K) on 2019-02-15, disclosed to the SEC on 2019-02-19.
Open-market sale of $562k MRTX by Senior VP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRTX | SELL | 2018-03-02 | $2.1M | — | Filing → |